Superstring Capital Management LP
- SEC CIK
- 0001931118
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 14, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 35
- −10 vs. Q4 2025
- Portfolio value
- $140.0M
- −$46.8M (−25.1%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SMMTSummit Therapeutics Inc. | COM | 892,873 | $16.9M | 12.1% | +892,873 | New | History |
| IMVTImmunovant, Inc. | COM | 357,606 | $8.88M | 6.3% | +68,929+23.9% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 225,158 | $8.67M | 6.2% | −141,080−38.5% | Reduced | History |
| SVRASavara Inc | COM | 1,585,977 | $8.66M | 6.2% | +590,624+59.3% | Added | History |
| URGNUroGen Pharma Ltd. | COM | 387,371 | $6.96M | 5.0% | −330,983−46.1% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 351,461 | $6.64M | 4.7% | −73,741−17.3% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 730,548 | $6.55M | 4.7% | +730,548 | New | History |
| PCVXVaxcyte, Inc. | COM | 110,454 | $6.42M | 4.6% | +110,454 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 180,048 | $5.71M | 4.1% | +91,740+103.9% | Added | History |
| SIONSionna Therapeutics, Inc. | COM | 141,024 | $5.65M | 4.0% | −39,569−21.9% | Reduced | History |
| GMABGenmab A/S | SPONSORED ADS | 196,709 | $5.28M | 3.8% | +167,547+574.5% | Added | History |
| ZLABZai Lab Ltd | ADR | 275,818 | $5.19M | 3.7% | +78,965+40.1% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 11,010 | $4.92M | 3.5% | +11,010 | New | History |
| IQVIQVIA Holdings Inc. | Stock | 25,668 | $4.38M | 3.1% | +25,668 | New | History |
| MPLTMapLight Therapeutics, Inc. | COM | 192,139 | $3.91M | 2.8% | +192,139 | New | History |
| ARVNArvinas, Inc. | COM | 312,620 | $3.31M | 2.4% | +312,620 | New | History |
| ORKAOruka Therapeutics, Inc. | COM | 63,591 | $3.12M | 2.2% | +63,591 | New | History |
| UTHRUnited Therapeutics Corp | COM | 5,186 | $3.08M | 2.2% | −4,265−45.1% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 102,754 | $3.05M | 2.2% | +64,732+170.2% | Added | History |
| TRVITrevi Therapeutics, Inc. | COM | 251,566 | $3.00M | 2.1% | +103,274+69.6% | Added | History |
| ANLAdlai Nortye Group Ltd. | ADS | 414,852 | $2.87M | 2.1% | +414,852 | New | History |
| CABACabaletta Bio, Inc. | COM | 1,066,239 | $2.87M | 2.0% | −1,187,311−52.7% | Reduced | History |
| PFEPfizer Inc | Stock | 74,000 | $2.08M | 1.5% | +74,000 | New | History |
| AXSMAxsome Therapeutics, Inc. | COM | 11,217 | $1.90M | 1.4% | −26,216−70.0% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 115,234 | $1.46M | 1.0% | −140,136−54.9% | Reduced | History |
| ACRSAclaris Therapeutics, Inc. | COM | 366,490 | $1.37M | 1.0% | +366,490 | New | History |
| CLYMClimb Bio, Inc. | COM | 199,209 | $1.36M | 1.0% | +199,209 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 258,269 | $1.15M | 0.8% | −722,499−73.7% | Reduced | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 13,311 | $971.3K | 0.7% | −33,967−71.8% | Reduced | History |
| TNXPTonix Pharmaceuticals Holding Corp. | COM NEW | 63,540 | $873.7K | 0.6% | +63,540 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 59,484 | $845.3K | 0.6% | +59,484 | New | History |
| TARAProtara Therapeutics, Inc. | COM STK | 121,457 | $632.8K | 0.5% | −238,543−66.3% | Reduced | History |
| PTNPalatin Technologies Inc | COM NEW | 35,969 | $626.6K | 0.4% | +1,998+5.9% | Added | History |
| BMEABiomea Fusion, Inc. | COM | 250,000 | $382.5K | 0.3% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 119,308 | $269.6K | 0.2% | −343,655−74.2% | Reduced | History |
Sold out since Q4 2025 (24)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| CDTXCidara Therapeutics, Inc. | COM NEW | 85,098 | $18.8M | 10.1% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 443,777 | $17.9M | 9.6% | History |
| DVAXDynavax Technologies Corp | COM NEW | 525,592 | $8.08M | 4.3% | History |
| OCULOcular Therapeutix, Inc | COM | 418,080 | $5.08M | 2.7% | History |
| FOLDAmicus Therapeutics, Inc. | COM | 352,896 | $5.03M | 2.7% | History |
| RVMDRevolution Medicines, Inc. | COM | 54,879 | $4.37M | 2.3% | History |
| BLTEBelite Bio, Inc | SPONSORED ADS | 24,703 | $3.95M | 2.1% | History |
| ZBIOZenas BioPharma, Inc. | COM | 83,353 | $3.03M | 1.6% | History |
| QNCXQuince Therapeutics, Inc. | COM | 858,711 | $2.88M | 1.5% | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 153,313 | $2.78M | 1.5% | History |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 96,334 | $2.78M | 1.5% | History |
| PVLAPalvella Therapeutics, Inc. | COM | 25,469 | $2.67M | 1.4% | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 65,273 | $2.22M | 1.2% | History |
| TYRATyra Biosciences, Inc. | COM | 58,677 | $1.54M | 0.8% | History |
| VRDNViridian Therapeutics, Inc. | COM | 43,230 | $1.35M | 0.7% | History |
| RZLTRezolute, Inc. | COM NEW | 513,765 | $1.21M | 0.6% | History |
| DNTHDianthus Therapeutics, Inc. | COM | 26,249 | $1.08M | 0.6% | History |
| SPRBSpruce Biosciences, Inc. | COM NEW | 12,137 | $1.06M | 0.6% | History |
| AARDAardvark Therapeutics, Inc. | COM | 69,496 | $912.1K | 0.5% | History |
| PALIPalisade Bio, Inc. | COM | 367,103 | $862.7K | 0.5% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 72,060 | $815.0K | 0.4% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 31,738 | $730.0K | 0.4% | History |
| IVAInventiva S.A. | ADS | 100,000 | $465.0K | 0.2% | History |
| ENTXEntera Bio Ltd. | SHS | 17,142 | $33.3K | <0.1% | History |